Therefore, the present study suggests that the combined detection of HE4 and CA125 contributes to the differential diagnosis of benign or malignant pelvic masses, but is not superior to the single detection of HE4 for the early diagnosis of ovarian cancer. Here, WFDC2 is linked to ovarian carcinoma.